<--- Back to Details
First PageDocument Content
Pharmaceutical industry / Pharmaceutics / Food and Drug Administration / Bioequivalence / Pharmacokinetics / Generic drug / Abbreviated New Drug Application / NIPTE / Center for Drug Evaluation and Research / Pharmaceutical sciences / Pharmacology / Pharmaceuticals policy
Pharmaceutical industry
Pharmaceutics
Food and Drug Administration
Bioequivalence
Pharmacokinetics
Generic drug
Abbreviated New Drug Application
NIPTE
Center for Drug Evaluation and Research
Pharmaceutical sciences
Pharmacology
Pharmaceuticals policy

Generic Drug User Fee Amendments of 2012 Regulatory Science Initiatives:

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 55,35 KB

Share Document on Facebook

Similar Documents

JPPT Review Article Developmental Pharmacokinetics in Pediatric Populations Hong Lu, PhD and Sara Rosenbaum, PhD Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, Rhode Island

DocID: 1vmzU - View Document

Extrapolation of Fenfluramine Pharmacokinetics from Adults to Children: Estimating PK Exposure in Patients with Dravet Syndrome Li Zhang, Brooks Boyd, Christopher M. Rubino 1 METHODS

DocID: 1v6zS - View Document

Human Metabolism of a Novel Chemotherapeutic: Illuminating the Mechanisms of P450-Catalyzed Deboronation J. Scott Daniels Pharmacokinetics, Dynamics and Metabolism

DocID: 1uU9P - View Document

Plasma Protein Binding: Friend or Foe in Drug Discovery? Kevin Beaumont and Tristan Maurer Pharmacokinetics, Dynamics and Metabolism Pfizer Worldwide Research and Development Memorial Drive, Cambridge

DocID: 1uQg4 - View Document

Pharmacokinetics and efficacy of intraocular flurbiprofen

DocID: 1uLR6 - View Document